Tag Archive: coronary heart disease (CHD)

Dec 17

The US Food and Drug Administration (FDA) has approved a screening test that measures serum lipoprotein-associated phospholipase A2 (Lp-PLA2) for the assessment of coronary heart disease (CHD)

The US Food and Drug Administration (FDA) has approved a screening test that measures serum lipoprotein-associated phospholipase A2 (Lp-PLA2) for the assessment of coronary heart disease (CHD) risk in patients without existing disease. The approval is based on a substudy of the Reasons for Geographic and Racial Differences in Stroke study.

Nov 13

In a single-center study, only 17% of hospitalized nonsmokers with coronary heart disease (CHD)

In a single-center study, only 17% of hospitalized nonsmokers with coronary heart disease (CHD) were asked about exposure to tobacco smoke, and only 1.4% remembered receiving any advice about this modifiable risk factor, reported researchers. The study thus suggests that clinicians are missing an important teachable moment. The report is published online in JAMA Internal …

Continue reading »

Aug 29

Innovations in Cardiology (IIC) Summit 2014

Dr Rajneesh Kapoor Fat intake and heart risk A 2014 meta–analysis of prospective observational studies found no association between intake of saturated fat and risk for coronary heart disease (CHD). The meta–analysis, published in Ann Intern Med. 2014 Mar 18;160(6):398–406, also found no relationship between monounsaturated fat intake and CHD, but suggested a reduction in …

Continue reading »

Jul 16

A new analysis of patients with newly diagnosed coronary heart disease (CHD)

A new analysis of patients with newly diagnosed coronary heart disease (CHD) has pointed that the benefits of beta–blockers in this setting appear downgraded only to those with a recent MI. The analysis revealed that the use of beta–blockers was associated with an overall 10% lower risk of mortality and an 8% lower risk of …

Continue reading »